Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Alector, Inc. | Director, 10%+ Owner | Common Stock | 10.9M | $60.3M | $5.56 | Sep 11, 2023 | Indirect |
Invivyd, Inc. | Director | Common Stock | 4.69M | $7.78M | $1.66 | May 29, 2024 | Indirect |
Alector, Inc. | Director, 10%+ Owner | Common Stock | 55K | $306K | $5.56 | Sep 11, 2023 | Direct |
Seer, Inc. | Director | Class A Common Stock | 91.6K | $186K | $2.03 | Jun 12, 2024 | Direct |
Seer, Inc. | Director | Class A Common Stock | 78.9K | $160K | $2.03 | Jun 12, 2024 | Indirect |
Cyclerion Therapeutics, Inc. | Director | Common Stock | 34.9K | $118K | $3.40 | Nov 30, 2023 | By Polaris Partners VIII, L.P |
Tectonic Therapeutic, Inc. | Director | Common Stock | 64.7K | $84K | $1.30 | Jun 20, 2024 | Indirect |
Cyclerion Therapeutics, Inc. | Director | Common Stock | 5.55K | $18.8K | $3.40 | Nov 30, 2023 | Direct |
Cyclerion Therapeutics, Inc. | Director | Common Stock | 1.25K | $4.23K | $3.40 | Nov 30, 2023 | By Polaris Entrepreneurs 'Fund VIII, L.P. |
Cyclerion Therapeutics, Inc. | Director | Common Stock | 345 | $1.17K | $3.40 | Nov 30, 2023 | By Bartlett Partners, LLC |
Invivyd, Inc. | Director | Stock Option (Right to Buy) | 50K | May 21, 2024 | Direct | ||
Seer, Inc. | Director | Stock Option (right to buy) | 34.7K | Jun 14, 2023 | Direct | ||
Tectonic Therapeutic, Inc. | Director | Stock Option (Right to Buy) | 11.8K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TECX | Tectonic Therapeutic, Inc. | Jun 20, 2024 | 4 | $0 | 4 | Jun 24, 2024 | Director |
TECX | Tectonic Therapeutic, Inc. | Jun 20, 2024 | 0 | $0 | 3 | Jun 24, 2024 | Director |
SEER | Seer, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
IVVD | Invivyd, Inc. | May 29, 2024 | 1 | -$187K | 4 | May 31, 2024 | Director |
IVVD | Invivyd, Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
CYCN | Cyclerion Therapeutics, Inc. | Nov 30, 2023 | 1 | $0 | 4 | Dec 4, 2023 | Director |
ALEC | Alector, Inc. | Sep 11, 2023 | 1 | -$3M | 4 | Sep 13, 2023 | Director, 10%+ Owner |
ALEC | Alector, Inc. | Aug 22, 2023 | 5 | $0 | 4 | Aug 24, 2023 | Director, 10%+ Owner |
CYCN | Cyclerion Therapeutics, Inc. | Aug 9, 2023 | 1 | -$27 | 4 | Aug 11, 2023 | Director |
SEER | Seer, Inc. | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
ALEC | Alector, Inc. | Jun 14, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Director, 10%+ Owner |
IVVD | Invivyd, Inc. | May 23, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
ALEC | Alector, Inc. | Nov 16, 2022 | 5 | $0 | 4 | Nov 18, 2022 | Director, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
ALEC | Alector, Inc. | Jun 16, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
SEER | Seer, Inc. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
CYCN | Cyclerion Therapeutics, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
IVVD | Adagio Therapeutics, Inc. | Mar 28, 2022 | 0 | $0 | 4 | Mar 30, 2022 | Director, Other* |
ALEC | Alector, Inc. | Dec 21, 2021 | 5 | $0 | 4 | Dec 23, 2021 | Director, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Aug 10, 2021 | 28 | $8.5M | 4 | Aug 12, 2021 | Director |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 1 | $0 | 4 | Aug 9, 2021 | Director |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 0 | $0 | 3 | Aug 5, 2021 | Director |
CYCN | Cyclerion Therapeutics, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 28, 2021 | Director |
SEER | Seer, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
ALEC | Alector, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
CYCN | Cyclerion Therapeutics, Inc. | Jun 3, 2021 | 2 | $300K | 4 | Jun 7, 2021 | Director |